Bile acids that bind taurine and glycine could reduce the nuclear factor kappa‐B level by activating TGR5, leading to a decrease in proinflammatory cytokine levels, further inhibiting inflammation in atherosclerotic plaques and development of atherosclerosis.60 This evidence concerns the gene GPBAR1 and atherosclerosis.